Endovascular repair

血管内修复术
  • 文章类型: Journal Article
    目的:本研究旨在评估复杂动脉瘤血管内手术修复过程中与上肢导管插入术相关的疗效和并发症。
    方法:遵循PRISMA指南进行了系统评价,涉及在PubMed上进行搜索,科克伦中部,和WebofScience。主要终点是30天的卒中。次要终点是目标血管技术成功,30天死亡率,局部通路相关并发症。使用随机效应模型进行Meta分析。
    结果:纳入了16项观察性研究,包括4,137名患者。上肢通道的30天中风发生率为1.4%(95%CI1.0%-1.8%),略高于下肢,尽管没有统计学意义。死亡率在0-6.8%之间变化,局部通路相关并发症发生率为3.2%(95%CI1.9%-4.4%).靶血管导管插入术的技术成功率为99.2%(95%CI98.4%-100.0%)。
    结论:这项系统评价和荟萃分析证明了f/b-EVAR上肢通路的安全性和有效性,中风风险低,死亡率,和最小的局部并发症。尽管存在偏见的风险,研究结果表明,上肢通道可能是有益的,尤其是在股骨通路失败的救助情况下,为临床决策提供有价值的见解。
    BACKGROUND: Catheterization of target vessels (TV) represented by renal visceral vessels are the crucial aspect during fenestrated and branched endovascular repair. This study aims to assess the efficacy and complications associated with upper limb catheterization during complex aneurysm endovascular surgery repair.
    METHODS: A systematic review was conducted after Preferred Reporting Items for a Systematic Review and Meta-analysis (PRISMA) guidelines, involving a search across PubMed, Cochrane CENTRAL, and Web of Science. Primary endpoint was represented by 30-day stroke. Secondary endpoints were target vessels\' (TVs) technical success, 30-day mortality, and local access-related complications. Meta-analyses were performed using a random-effects model.
    RESULTS: Sixteen observational studies encompassing 4,137 patients were included. The 30-day stroke incidence for upper limb access was 1.4% (95% CI 1.0-1.8%), which was slightly higher than lower limb, despite not statistically significant. Mortality varied between 0 and 6.8%, and local access-related complications occurred in 3.2% (95% CI 1.9-4.4%). Technical success in TV catheterization was 99.2% (95% CI 98.4-100.0%).
    CONCLUSIONS: This systematic review and meta-analysis demonstrate the safety and efficacy of upper limb access for Fenestrated and Branched Endovascular Aortic Repair (f/b-EVAR), with low stroke risk, mortality rates, and minimal local complications. Despite the risk of bias, the findings suggest that upper limb access may be beneficial, especially in bailout situations when femoral access fails, offering valuable insights for clinical decision-making.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    具有主动脉侵犯但无远处转移的T4b食管癌的发病率估计在所有食管癌病例的3.8%至4.6%之间。在这种情况下,主动脉食管瘘的发展是一种罕见但并非不太可能的事件,导致灾难性后果。这项系统评价的目的是评估主动脉支架置入术(胸血管内主动脉修复-TEVAR)的重要性及其在局部晚期食管癌治疗中的最佳时机。MEDLINE的系统文献检索,Scopus,谷歌学者数据库致力于确定截至2024年3月发表的相关研究。通过形成具有选择性和挽救性TEVAR亚组的患者队列来进行个体患者数据分析,取决于支架置入的时间。研究池由25项研究组成,包括101例局部晚期食道癌,年龄中位数为64岁(范围45-87岁)。其中,50例患者接受了选择性TEVAR,而在急性抢救环境中接受TEVAR的患者为51例。发现选择性或预防性TEVAR可显着提高食管切除率(65.6%vs.救助亚组的16.7%,P<0.001),同时降低并发症发生率(8.3%vs.36.1%,P<0.001)。选择性亚组的总生存期也延长(8.3vs.4个月,P=0.001),选择性支架置入术是提高生存率的唯一独立预测因素。总之,对高危患者进行主动脉支架置入治疗可以减少大出血的灾难性后果,尽量减少并发症,提高生存率。
    The incidence of T4b esophageal cancer with aortic invasion but without distant metastasis is estimated to be between 3.8% and 4.6% of all esophageal cancer cases. Development of an aortoesophageal fistula in such cases is a rare but not unlikely event, leading to catastrophic consequences. The aim of this systematic review is to evaluate the importance of aortic stenting (Thoracic Endovascular Aortic Repair-TEVAR) and its optimal timing in the management of locally advanced esophageal cancer. A systematic literature search of the MEDLINE, Scopus, and Google Scholar databases was undertaken to identify relevant studies published up to March 2024. An individual patient data analysis was performed by forming a patient cohort with elective and salvage TEVAR subgroups, depending on the timing of the stenting. The study pool consisted of 25 studies incorporating 101 cases of locally advanced esophageal cancer, with a median age of 64 years (range 45-87 years). Of them, 50 patients underwent elective TEVAR compared with 51 patients receiving TEVAR in an acute salvage setting. Elective or prophylactic TEVAR was found to significantly increase esophageal resection rates (65.6% vs. 16.7% in the salvage subgroup, P < 0.001), concurrently reducing complication rates (8.3% vs. 36.1%, P < 0.001). Overall survival was also prolonged in the elective subgroup (8.3 vs. 4 months, P = 0.001), with elective stenting being the only independent predictor of improved survival. In conclusion, management with aortic stenting in high-risk patients may reduce the catastrophic consequences of massive bleeding, minimize complications, and enhance survival rates.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:钝性创伤性主动脉损伤(BTAI)是年轻患者因创伤导致死亡的第二大原因。主要表现可能是胸部或肩胛骨间疼痛,呼吸困难,and,在严重的情况下,低血压。考虑到这些患者的临床状况迅速恶化,及时诊断和开始治疗至关重要。在这些伤害中,主动脉受累最多的部分是峡部(左锁骨下动脉远端)和胸腔的降部。因此,主要的诊断策略包括经胸超声心动图,CT血管造影,和血管内诊断方法。病例介绍患者是一名19岁男性,有胸痛症状,呼吸困难,汽车周转后四肢极度疼痛。初步评估显示,除了双侧血胸,没有异常的心血管发现。用胸管处理。十二小时后,当病人接受骨科手术观察时,他开始胸痛和呼吸困难,TTE和CTA显示主动脉瓣三降动脉瘤。患者立即接受了支架植入的血管内手术治疗。还进行了延迟脱支手术,这导致了理想的结果和顺利的后续行动。
    结论:尽管开胸手术是治疗血流动力学不稳定患者主动脉瘤的主要且几乎是唯一的选择,在具有适当解剖结构的选定患者中,血管内手术显示出优异的结局。脱支手术,可以在初始程序之后同时或延迟进行,已证明对血栓栓塞性脑事件有保护作用。
    主动脉瘤患者应与多学科小组一起送往医疗中心进行紧急评估和治疗。最初的复苏和诊断具有挑战性,考虑到这些伤害的致命性质,治疗方法的选择是基于患者的临床状况和心血管影像学的解剖学评估。
    BACKGROUND: Blunt traumatic aortic injury (BTAI) is the second leading cause of death due to traumas in young patients. The primary presentation might be chest or interscapular pain, difficulty in breathing, and, in severe cases, hypotension. Considering the rapid deterioration of these patients\' clinical conditions, prompt diagnosis and treatment initiation are crucial. In these injuries, the most involved parts of the aorta are the isthmus (distal to the left subclavian artery) and the descending part in the thorax. Therefore, the main diagnostic strategies include transthoracic echocardiography, CT angiography, and endovascular diagnostic approaches. Case presentation The patient was a 19-year-old male presenting with the symptoms of chest pain, dyspnea, and extremities excruciating pain after a car turnover. The initial evaluation showed no abnormal cardiovascular finding except bilateral hemothorax, addressed with chest tubes. Twelve hours later, when the patient was under observation for orthopedic surgeries, his chest pain and dyspnea started, and TTE and CTA showed a grade three descending aneurysm of the aorta. The patient was treated immediately with an endovascular procedure of stent implantation. A delayed debranching surgery was also performed, which resulted in desirable outcomes and uneventful follow-up.
    CONCLUSIONS: Although open thoracic surgery is the main and almost the only option for treating aneurysms of the aorta in hemodynamically unstable patients, the endovascular procedure has shown superior outcomes in selected patients with appropriate anatomy. Debranching surgery, which can be done simultaneously or with delay after the initial procedure, has proven protective against thromboembolic cerebral events.
    UNASSIGNED: Patients with an aneurysm of the aorta should be transported to a medical center with a multidisciplinary team for an urgent evaluation and treatment. The initial resuscitation and diagnosis are challenging, considering the fatal nature of these injuries, and the selection of the treatment is based on the patient\'s clinical condition and evaluated anatomy in cardiovascular imaging.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    肝动脉瘤(HAAs)是一种罕见的血管疾病,占内脏动脉瘤的20%。大多数患者通常无症状,并在成像控制期间意外发现,但偶尔,它们可以表现为急性腹痛,胆道出血,阻塞性黄疸,或因动脉瘤囊扩张或破裂引起的消化道出血,造成灾难性后果。我们介绍了一名51岁的男性患者,其巨大的普通HAA为11.1厘米,并接受了血管内治疗。由于动脉瘤的解剖结构,决定了血管内联合入路。在动脉瘤的远端部分使用线圈进行血管内栓塞,并在近端部署支架移植物以排除流入。六个月的时候,动脉瘤大小在5厘米处回归;然而,手术后7个月,患者由于线圈迁移而出现幽门穿孔,这是通过线圈切除来管理的,周围胃切除术,和Roux-en-Y胃旁路术.我们提供了有关巨大HAAs的血管内修复的叙述性文献综述。PubMed,Scopus,直到2024年1月,谷歌学者数据库都被搜索到了文章。38项研究(病例报告,案例系列)被检索。结论是,巨大的HAAs是一种罕见且严重的疾病,其治疗可能具有挑战性,并伴有意外的不良事件。文献综述表明,只要可行,血管内途径是一种安全有效的治疗选择,发病率和死亡率低。
    Hepatic artery aneurysms (HAAs) are an uncommon vascular disease, which account for 20% of visceral artery aneurysms. The majority are usually asymptomatic and discovered accidentally during imaging control, but occasionally, they can present as acute abdominal pain, haemobilia, obstructive jaundice, or gastrointestinal bleeding due to aneurysm sac expansion or rupture with catastrophic consequences. We present the case of a 51-year-old male patient with a giant common HAA of 11.1 cm who was managed endovascularly. A combined endovascular approach was decided due to the anatomy of the aneurysm. Endovascular embolization with coils in the distal part of the aneurysm and deployment of a stent graft proximally to exclude inflow were used. At six months, the aneurysm size was regressed at 5 cm; however, seven months after the operation, the patient presented with pylorus perforation due to coil migration which was managed by coil removal, peripheral gastrectomy, and Roux-en-Y gastric bypass. We provide a narrative literature review regarding the endovascular repair of giant HAAs. The PubMed, Scopus, and Google Scholar databases were searched for articles up to January 2024. Thirty-eight studies (case reports, case series) were retrieved. The conclusion is that giant HAAs are a rare and severe condition in which their treatment can be challenging with unexpected adverse events. The literature review suggests that the endovascular approach whenever feasible is a safe and effective treatment option with low morbidity and mortality.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    右锁骨下动脉异常(ARSA)导致吞咽困难,所谓的“lusoria吞咽困难”,是主动脉弓的常见胚胎异常。在有症状的患者中,研究报告了几种管理选择,包括外科手术,混合动力车,和完全的血管内策略。混合技术的优点是没有胸部开口,发病率降低,但在某些病例中,ARSA残端引起复发性或持续性吞咽困难的问题仍然具有挑战性.我们对ARSA的管理策略进行了文献综述,并介绍了一名72岁的ARSA和吞咽困难的女性患者,该患者采用胸主动脉腔内修复术(TEVAR)和双侧颈动脉锁骨下动脉旁路术。选择此技术是因为ARSA起源水平的严重钙化会使手术结扎困难,或者如果封堵器装置不合适。我们认为,在吞咽困难的情况下,应考虑患者量身定制的方法,考虑到报告了多种策略。
    Aberrant right subclavian artery (ARSA) causing dysphagia, the so-called \"dysphagia lusoria\", is a frequent embryologic anomaly of the aortic arch. In symptomatic patients, studies report several management options including surgical, hybrid, and totally endovascular strategies. Hybrid techniques have the advantage of no chest opening with reduced morbidity, but the problem of the ARSA stump causing recurrent or persistent dysphagia remains challenging in some cases. We conducted a literature review on the management strategies of ARSA and presented the case of a 72-year-old female patient with ARSA and dysphagia managed with thoracic endovascular repair of the aorta (TEVAR) and bilateral carotid-subclavian artery bypass. This technique was chosen because of the severe calcifications at the level of ARSA origin that would make surgical ligation difficult, or if an occluder device not suitable. We think that a patient-tailored approach should be considered in cases of dysphagia lusoria, considering that a multitude of strategies are reported.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    开窗式血管内动脉瘤修复术(FEVAR)和烟囱式血管内动脉瘤修复术(ChEVAR)治疗近肾主动脉瘤(JAAs)的疗效比较尚不清楚。我们的目标是识别和分析当前的证据体系,比较两种技术对JAA的有效性。
    我们进行了系统评价和荟萃分析,比较了FEVAR和ChEVAR对JAA修复的有效性。我们搜索了MEDLINE,EMBASE,和Cochrane注册自1990年1月1日起进行对照试验,用于评估FEVAR和ChEVAR用于JAA修复的结果的随机和非随机研究。筛选,数据提取,偏见风险评估,和等级(建议的等级,评估,发展,和评估)证据的确定性一式两份。在可能的情况下对数据进行统计汇总。
    纳入9项回顾性队列研究,比较FEVAR和ChEVAR治疗近肾动脉瘤的疗效。荟萃分析的FEVAR和ChEVAR臂由726名参与者和518名参与者组成,分别。每个手臂有598名(86.8%)和332名(81.6%)男性。ChEVAR臂的平均直径较大(59mmvs52.5mm)。两种技术术后30天死亡率相似,3.38%(8/237)与3.52%(8/227),急性肾损伤,16.76%(31/185)与17.31%(18/104),和主要不良心脏事件,7.30%(46/630)与6.60%(22/333)。荟萃分析支持将FEVAR用于大多数结果,具有技术成功的显着优势(优势比[OR]:3.24,95%CI:1.24-8.42)和避免1型内漏(OR:5.76,95%CI:1.94-17.08),但对脊髓缺血不利(OR:10.21,95%CI:1.21-86.11),事件数量很少。大多数结果的证据质量是“中等”的。
    两种血管内技术均具有良好的安全性。证据不支持FEVAR或ChEVAR对JAA的优越性。
    虽然缺乏平衡阻碍了开腹与腔内修复术治疗近肾主动脉瘤的随机试验的设计,对血管内修复术的耐久性的关注凸显了需要更有力的证据来证明血管内技术的比较疗效.这篇综述对大型观察性研究的最新数据进行了荟萃分析和证据评估,比较了开窗和烟囱技术,使用全面的结果集。由于每个研究组参与者基线风险的差异,任何一种干预措施的优势都无法确定。然而,数据表明,两种技术都是安全的,适合在指示时使用。
    UNASSIGNED: Comparative effectiveness of fenestrated endovascular aneurysm repair (FEVAR) and chimney graft endovascular aneurysm repair (ChEVAR) for juxtarenal aortic aneurysms (JAAs) remains unclear. Our objective was to identify and analyze the current body of evidence comparing the effectiveness of both techniques for JAA.
    UNASSIGNED: We performed a systematic review and meta-analysis comparing the effectiveness of FEVAR and ChEVAR for JAA repair. We searched MEDLINE, EMBASE, and Cochrane Register for Controlled Trials from January 1, 1990, for randomized and non-randomized studies assessing outcomes of FEVAR and ChEVAR for JAA repair. Screening, data extraction, risk of bias assessment, and GRADE (Grading of Recommendations, Assessments, Development, and Evaluations) certainty of evidence were performed in duplicate. Data were pooled statistically where possible.
    UNASSIGNED: Nine retrospective cohort studies comparing the use of FEVAR and ChEVAR for juxtarenal aneurysm were included for meta-analysis. The FEVAR and ChEVAR arms of the meta-analysis consisted of 726 participants and 518 participants, respectively. There were 598 (86.8%) and 332 (81.6%) men in each arm. The mean diameter was larger in the ChEVAR arm (59 mm vs 52.5 mm). Both techniques had similar rates of postoperative 30-day mortality, 3.38% (8/237) versus 3.52% (8/227), acute kidney injury, 16.76% (31/185) versus 17.31% (18/104), and major adverse cardiac events, 7.30% (46/630) versus 6.60% (22/333). The meta-analysis supported the use of FEVAR for most outcomes, with significant advantage for technical success (odds ratio [OR]: 3.24, 95% CI: 1.24-8.42) and avoidance of type 1 endoleak (OR: 5.76, 95% CI: 1.94-17.08), but a disadvantage for spinal cord ischemia (OR: 10.21, 95% CI: 1.21-86.11), which had a very low number of events. The quality of evidence was \"moderate\" for most outcomes.
    UNASSIGNED: Both endovascular techniques had good safety profiles. The evidence does not support superiority of either FEVAR or ChEVAR for JAA.
    UNASSIGNED: While lack of equipoise has hampered the design of randomised trials of open versus endovascular repair of juxtarenal aortic aneurysms, concern about the durability of endovascular repair highlights the need for stronger evidence of the comparative efficacy of endovascular techniques. This review performed meta-analysis and evidence appraisal of recent data from large observational studies comparing fenestrated and chimney techniques, using a comprehensive outcome set. Superiority of either intervention could not be established due to differences in participants\' baseline risk in each study arm. However, data suggests that both techniques are safe and suitable for use when indicated.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    钝性胸主动脉损伤(BTAI)是一种潜在的危及生命的疾病,目前的指南建议将胸主动脉腔内修复术(TEVAR)作为一线治疗(I级证据C)。本系统评价的目的是确定接受TEVAR治疗的BTAI患者的围手术期和中期随访结果。
    我们回顾了2000年至2022年之间通过Ovid发表的英文文献,使用MEDLINE,EMBASE,和中央数据库,直到2022年7月30日。观察性研究和案例系列,≥5名患者,纳入了接受TEVAR治疗BTAI的患者的围手术期和随访结局的报告.纽卡斯尔-渥太华量表用于评估偏倚风险。主要结果是技术成功和30天死亡率,脑血管发病率。次要结果是中期随访期间的死亡率和再次干预。
    来自文献检索的5201篇文章,35项符合条件的研究纳入本综述。所有研究均采用回顾性研究设计。总的来说,纳入991例患者。平均年龄为34.5±16.5岁(范围=16-89岁)。技术成功率为98.0%(赔率比[OR],95%置信区间[CI]=0.98,0.99,p<0.001,I2=0%)。30天的死亡率为5.0%(OR,95%CI=0.03,0.06,p<0.001,I2=5.56%)。脊髓缺血发生率为1.0%(OR,95%CI=0.01,0.02,p<0.001,I2=0%),卒中发生率为2.0%(OR,95%CI=0.01,0.02,p<0.001,I2=0%)。可用的随访时间估计为29个月(范围=3-119个月),死亡率为2.0%(OR,95%CI=0.01,0.02,p<0.001,I2=0%),再干预率为1.0%(OR,95%CI=0.01,0.02,p<0.001,I2=10.5%)。
    胸主动脉腔内修复术显示出很高的技术成功率和较低的早期脑血管发病率和死亡率。在中期随访中,估计死亡率和再干预率也较低.此外,需要更高质量的前瞻性研究。
    结论:建议胸主动脉腔内修复术(TEVAR)作为钝性胸主动脉损伤(BTAI)患者的一线治疗方法。这项对35项回顾性研究和991例患者的系统评价显示,技术成功率很高(98.0%),相关的30天死亡率为5.0%,脊髓缺血(1%)和中风率(2.0%)较低。中期死亡率和再干预率确保了TEVAR在BTAI病例中的有效性。
    UNASSIGNED: Blunt thoracic aortic injury (BTAI) represents a potentially life-threatening condition and thoracic endovascular aortic repair (TEVAR) is recommended as the first-line treatment (Class I level of evidence C) by the current guidelines. The aim of this systematic review was to determine the perioperative and mid-term follow-up outcomes of patients with BTAI treated with TEVAR.
    UNASSIGNED: We reviewed the English literature published between 2000 and 2022, via Ovid, using MEDLINE, EMBASE, and CENTRAL databases, until July 30, 2022. Observational studies and case series, with ≥5 patients, reporting on the perioperative and follow-up outcomes of patients who underwent TEVAR for BTAI were included. The Newcastle-Ottawa Scale was used to assess the risk of bias. Primary outcomes were technical success and 30-day mortality, cerebrovascular morbidity. Secondary outcomes were mortality and re-interventions during the mid-term follow-up.
    UNASSIGNED: From 5201 articles identified by the literature search, 35 eligible studies were included in this review. All studies had a retrospective study design. In total, 991 patients were included. The mean age was 34.5±16.5 years (range=16-89 years). Technical success was 98.0% (odds ratio [OR], 95% confidence interval [CI]=0.98, 0.99, p<0.001, I2=0%). Mortality at 30 days was 5.0% (OR, 95% CI=0.03, 0.06, p<0.001, I2=5.56%). Spinal cord ischemia occurred in 1.0% (OR, 95% CI=0.01, 0.02, p<0.001, I2=0%) and stroke rate was 2.0% (OR, 95% CI=0.01, 0.02, p<0.001, I2=0%). The available follow-up was estimated at 29 months (range=3-119 months) with mortality rate at 2.0% (OR, 95% CI=0.01, 0.02, p<0.001, I2=0%) and re-intervention rate at 1.0% (OR, 95% CI=0.01, 0.02, p<0.001, I2=10.5%).
    UNASSIGNED: Thoracic endovascular aortic repair showed high technical success and low early cerebrovascular morbidity and mortality rates. In the mid-term follow-up, the estimated mortality and re-intervention rates were also low. Furthermore, higher quality prospective studies are needed.
    CONCLUSIONS: Thoracic endovascular aortic repair (TEVAR) is recommended as the first line treatement in patients with blunt thoracic aortic injuries (BTAI). This systematic review of 35 retrospective studies and 991 patients showed high technical success (98.0%) with an associated 30-day mortality at 5.0% and low spinal cord ischemia (1%) and stroke rates (2.0%). Mid-term mortality and re-intervention rates reassure the effectiveness of TEVAR in BTAI cases.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Systematic Review
    背景:非主动脉动脉损伤很常见,并且与高发病率和高死亡率相关。历史上,开放手术修复(OSR)是传统的修复方法。随着微创技术的最新进展,血管内修复术(ER)已经普及。我们试图比较接受血管内修复和开放修复的患者的结果创伤性非主动脉穿透性动脉损伤。
    方法:使用MEDLINE(OVID)进行系统评价和荟萃分析,WebofScience,科克伦图书馆,和Scopus数据库从1月1日开始,1990年3月20日,2023年。标题和摘要进行了筛选,其次是全文回顾。包括评估OSR和ER在穿透性动脉损伤中临床重要结果的文章。排除标准包括钝器伤,主动脉损伤,儿科人群,评论文章,非英语文章使用赔率比(OR)和Cohen'sd比率来量化发病率和死亡率的差异。
    结果:共确定3770篇文章,其中8人符合纳入标准,并被纳入审查。这些文章包括总共8369名患者,其中90%为男性,中位年龄为28岁。85%的患者接受了OSR治疗,15%的患者接受了ER治疗。关于伤害特征,接受ER的患者并发静脉损伤的可能性较小(OR:0.41;95CI:0.18,0.94;p=0.03).关于医院的结果,接受ER治疗的患者住院或30日死亡率(OR:0.72;95CI:0.55,0.95;p=0.02)和室综合征(OR:0.29,95CI:0.12,0.71;p=0.007)的可能性较低.总体偏倚风险中等。
    结论:非主动脉穿透性动脉损伤的腔内修复越来越普遍,然而,开放式修复仍然是最常见的方法。与ER相比,OSR与更高的骨筋膜室综合征和死亡率相关。进一步的前瞻性研究是必要的,以确定患者人群和损伤模式,最显著受益于血管内途径。
    方法:三级,系统评价与荟萃分析。
    BACKGROUND: Non-aortic arterial injuries are common and are associated with high morbidity and mortality. Historically, open surgical repair (OSR) was the conventional method of repair. With recent advancements in minimally invasive techniques, endovascular repair (ER) has gained popularity. We sought to compare outcomes in patients undergoing endovascular and open repairs of traumatic non-aortic penetrating arterial injuries.
    METHODS: A systematic review and meta-analysis was conducted using MEDLINE (OVID), Web of Science, Cochrane Library, and Scopus Database from January 1st, 1990, to March 20th, 2023. Titles and abstracts were screened, followed by full text review. Articles assessing clinically important outcomes between OSR and ER in penetrating arterial injuries were included. Exclusion criteria included blunt injuries, aortic injuries, pediatric populations, review articles, and non-English articles. Odds ratios (OR) and Cohen\'s d ratios were used to quantify differences in morbidity and mortality.
    RESULTS: A total of 3770 articles were identified, of which 8 met inclusion criteria and were included in the review. The articles comprised a total of 8369 patients of whom 90 % were male with a median age of 28 years. 85 % of patients were treated with OSR while 15 % underwent ER. With regards to injury characteristics, those who underwent ER were less likely to present with concurrent venous injuries (OR: 0.41; 95 %CI: 0.18, 0.94; p = 0.03). Regarding hospital outcomes, patients who underwent ER had a lower likelihood of in-hospital or 30-day mortality (OR: 0.72; 95 %CI: 0.55, 0.95; p = 0.02) and compartment syndrome (OR: 0.29, 95 %CI: 0.12, 0.71; p = 0.007). The overall risk of bias was moderate.
    CONCLUSIONS: Endovascular repair of non-aortic penetrating arterial injuries is increasingly common, however open repair remains the most common approach. Compared to ER, OSR was associated with higher odds of compartment syndrome and mortality. Further prospective research is warranted to determine the patient populations and injury patterns that most significantly benefit from an endovascular approach.
    METHODS: Level III, Systematic Reviews & Meta-Analyses.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    肾动脉瘤(RVA)极为罕见,通常无症状,仅在计算机断层扫描和超声等诊断成像方式上偶然披露。管理通常只是警惕的后续行动,但有些病人需要干预.我们介绍了一名74岁的男子,该男子抱怨下腰痛,其中发现了53毫米RVA。他使用Amplatzer血管塞成功进行了血管内修复。动脉瘤在12个月内完全消退。以前似乎没有报道过原发性RVA的血管内治疗。这是RVA管理中的一个里程碑案例。
    Renal vein aneurysm (RVA) is extremely rare and often asymptomatic, disclosed only incidentally on diagnostic imaging modalities such as computed tomography and ultrasonography. Management is often just watchful follow-up, but some patients require intervention. We present the case of a 74-year-old man complaining of lower back pain in whom a 53-mm RVA was identified. He underwent successful endovascular repair using Amplatzer vascular plugs. The aneurysm had completely resolved by 12 months. Endovascular treatment of a primary RVA does not seem to have been reported previously. This is a milestone case in the management of RVA.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    主动脉瘤作为Takayasu动脉炎的表现特征非常罕见。这里,我们报告了3例大动脉炎中广泛的胸腹主动脉瘤作为初始表现。
    所有3例均为男性,并伴有腹痛和顽固性高血压。根据主动脉壁增厚和钙化的发现做出诊断。内脏动脉狭窄,诊断时年龄<40岁。病例1是一名34岁的男性,主动脉瘤从左锁骨下动脉延伸至肾下主动脉。鉴于即将发生动脉瘤破裂,他通过三明治烟囱技术进行了动脉瘤的血管内修复。病例2,一名37岁男性主动脉瘤从降胸主动脉(D4椎体)到肾下主动脉(L4水平)。在进行维修评估时,他可能是动脉瘤破裂导致猝死.案例三,一名40岁男性主动脉瘤从左锁骨下动脉延伸至主动脉分叉和内脏动脉狭窄。他不同意修复,一年后因慢性肾脏疾病和相关并发症死亡。
    胸腹主动脉瘤是Takayasu动脉炎中非常罕见的表现;在男性中更常见。血管内修复具有挑战性但可行。由于患者年龄小和疾病进展,可能需要长期监测和重复干预。
    UNASSIGNED: Aortic aneurysm as a presenting feature in Takayasu\'s arteritis is very rare. Here, we report three cases of extensive thoracoabdominal aortic aneurysm in Takayasu\'s arteritis as initial presentation.
    UNASSIGNED: All three cases were males and presented with complaints of abdominal pain and refractory hypertension. The diagnosis was made from the finding of thickened and calcified aortic wall, stenosis of visceral arteries, and age < 40 years at diagnosis. Case 1 was a 34 years male with aortic aneurysm extending from left subclavian artery to infrarenal aorta. He underwent endovascular repair of aneurysm by sandwich chimney technique in view of impending aneurysm rupture. Case 2, a 37 years male had aortic aneurysm from descending thoracic aorta (D4 vertebral body) to infrarenal aorta (L4 level). While being evaluated for repair, he had sudden death probably due to ruptured aneurysm. Case three, a 40 years male had aortic aneurysm extending from left subclavian artery to aortic bifurcation and stenosis of visceral arteries. He did not consent for repair and died one year later due to chronic kidney disease and related complications.
    UNASSIGNED: Thoracoabdominal aortic aneurysm is a very rare manifestation in Takayasu\'s arteritis; more common in males. Endovascular repair is challenging but feasible. Long-term monitoring and repeat intervention may be needed due to young age of patients and disease progression.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号